Dr. Ghosh on the Potential Advantages of Frontline CAR T-Cell Therapy in DLBCL
April 5th 2021
Nilanjan Ghosh, MD, PhD, discusses the potential advantages of moving CAR T-cell therapy into the frontline setting for patients with diffuse large B-cell lymphoma.